Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FR-188582 is a highly selective cyclooxygenase (COX)-2 inhibitor (IC50: 17 nM).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 11,700 | 6-8周 | ||
50 mg | ¥ 15,300 | 6-8周 | ||
100 mg | ¥ 19,500 | 6-8周 |
产品描述 | FR-188582 is a highly selective cyclooxygenase (COX)-2 inhibitor (IC50: 17 nM). |
靶点活性 | COX-2:17 nM |
体外活性 | FR-188582 inhibits COX-2 (IC50: 17 nM), in a recombinant human COX enzyme activity. The inhibition of prostaglandin (PG) E2 formation by FR188582 is over 6000 times more selective for COX-2 than COX-1. |
体内活性 | FR-188582 (0.01-3.2 mg/kg, p.o.) reverses paw edema in adjuvant arthritic rats and displays a therapeutic effect in a dose-dependent manner. For adjuvant-injected paws and adjuvant-uninjected paws, the ED50s values (95% C.L.) are 0.074 (0.00021-0.53) and 0.063 (0.0039-0.31) mg/kg , respectively. The anti-inflammatory effect of FR-188582 is threefold more potent than that of Indomethacin. For adjuvant-injected paws and adjuvant-uninjected paws, the ED50s values (95% C.L.) are 0.24 (0.047-1.8) and 0.20 (0.021-0.79) mg/kg, respectively. |
分子量 | 332.8 |
分子式 | C16H13ClN2O2S |
CAS No. | 189699-82-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
FR-188582 189699-82-9 Immunology/Inflammation Neuroscience COX FR 188582 FR188582 Inhibitor inhibitor inhibit